Ilyang Pharmaceutical has found the treatment substance of the “MERS virus”

Published: 2015-07-21 11:41:29

Updated: 2015-07-21 11:53:49

The Ilyang Pharmaceutical’s(President Dong-yeon Kim) ‘candidate substance of the MERS virus treatment’ has been proved in effectiveness by the Korean Society of Virology(President: Yong-soo Bae).

According to the company, it requested a verification for the candidate substance as finding out that the substance was well united with the ‘MERS virus’ in accordance of the computer simulation of Ko...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.